The pivotal Phase 3 AD clinical trial of buntanetap ( NCT06709014) is currently recruiting patients across the United States ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...

Maybe all that weightlifting hasn’t been in vein. Obesity has long been linked to Alzheimer’s disease and Parkinson’s disease because it can cause inflammation that harms the brain, among other ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

Researchers have identified a way to help the brain clear out proteins implicated in Parkinson's and Alzheimer's Disease.

Excess fat in certain areas of the human body could make people more prone to neurological diseases like Alzheimer’s and Parkinson’s, a new study suggests. The study, published in the journal ...

Now, new research by Penn State scientists has revealed this vital process may be governed by a previously unknown molecular ...

The latest announcement is out from Annovis Bio ( (ANVS) ).

VERO BEACH — The Alzheimer’s Foundation of America has awarded a grant to the Alzheimer & Parkinson Association of Indian River County to expand its Project Lifesaver program, which provides safety ...

News and commentary from the world of neurology and neuroscience ...

Despite growing recognition of the importance of the peripheral immune system in neurodegenerative disease, little is known about how these blood cells change in Alzheimer’s and Parkinson’s diseases.